NAPSA Polyclonal Antibody
| Code | Size | Price |
|---|
| E-AB-10821-20uL | 20uL | £125.00 |
Quantity:
| E-AB-10821-60uL | 60uL | £172.00 |
Quantity:
| E-AB-10821-120uL | 120uL | £237.00 |
Quantity:
| E-AB-10821-200uL | 200uL | £344.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunohistochemistry (IHC)
Shipping:
Ice packs
Storage:
-20°C
Further Information
Abbreviation:
NAPSA
Background:
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
Buffer:
PBS with 0.05% sodium azide and 50% glycerol, PH7.4
Concentration:
0.3 mg/mL
Conjugation:
Unconjugated
Dilution:
IHC 1:50-1:200
Immunogen:
Recombinant protein of human NAPSA
Purification method:
Affinity purification
Target Synonym:
Asp 4;ASP4;Aspartyl protease 4;KAP;Kdap;Kidney derived aspartic protease like protein;NAP1;NAPA;Napsa;NAPSA;Napsin 1;napsin A aspartic peptidase;Napsin A precursor;Napsin-1;Napsin-A;Pronapsin A;SNAPA;TA01/TA02
UNIProt ID:
O96009